Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
Open Access
- 16 March 2010
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (7), 1106-1112
- https://doi.org/10.1038/sj.bjc.6605618
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- α-Fetoprotein and human chorionic gonadotrophin-β as prognostic markers in neuroendocrine tumour patientsBritish Journal of Cancer, 2008
- Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumorsEndocrine-Related Cancer, 2007
- Cytotoxic treatment including embolization/chemoembolization for neuroendocrine tumoursBest Practice & Research Clinical Endocrinology & Metabolism, 2007
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading systemVirchows Archiv, 2006
- Phase II/III Study of Doxorubicin With Fluorouracil Compared With Streptozocin With Fluorouracil or Dacarbazine in the Treatment of Advanced Carcinoid Tumors: Eastern Cooperative Oncology Group Study E1281Journal of Clinical Oncology, 2005
- A Phase II trial of gemcitabine for metastatic neuroendocrine tumorsCancer, 2004
- Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell CarcinomaThe New England Journal of Medicine, 1992
- Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumorsCancer, 1990
- A phase II trial of combination chemotherapy in patients with metastatic carcinoid tumors. A southwest oncology group studyCancer, 1987
- Streptozocin Alone Compared with Streptozocin plus Fluorouracil in the Treatment of Advanced Islet-Cell CarcinomaThe New England Journal of Medicine, 1980